Ilan, Taiwan

Chia-Yu Pan

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Academia Sinica. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chia-Yu Pan. Retrieved from https://idiyas.com/inventor/chia-yu-pan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chia-Yu Pan: Innovator in Microbial Infection Treatments

Introduction

Chia-Yu Pan is a notable inventor based in Ilan, Taiwan. He has made significant contributions to the field of microbial infection treatments. His work focuses on innovative approaches to combat infections caused by various pathogens.

Latest Patents

Chia-Yu Pan holds 1 patent for his invention titled "Use of epinecidin-1 peptides and anti-lipopolysaccharide factor peptides for treating microbial infection." This patent specifically addresses the treatments of trichomonas, propionibacterium, or yeast infections using an epinecidin-1 peptide or an anti-lipopolysaccharide factor peptide.

Career Highlights

Chia-Yu Pan is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to explore and develop innovative solutions in the realm of microbial infections.

Collaborations

Chia-Yu Pan collaborates with Jyh-Yih Chen, contributing to advancements in their shared field of research.

Conclusion

Chia-Yu Pan's innovative work in microbial infection treatments showcases his dedication to improving health outcomes through scientific research. His contributions are valuable to the ongoing fight against infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…